Literature DB >> 19309260

NADPH oxidase 1 deficiency alters caveolin phosphorylation and angiotensin II-receptor localization in vascular smooth muscle.

Olivier Basset1, Christine Deffert, Michelangelo Foti, Karen Bedard, Vincent Jaquet, Eric Ogier-Denis, Karl-Heinz Krause.   

Abstract

The superoxide-generating NADPH oxidase NOX1 is thought to be involved in signaling by the angiotensin II-receptor AT1R. However, underlying signaling steps are poorly understood. In this study, we investigated the effect of AngII on aortic smooth muscle from wild-type and NOX1-deficient mice. NOX1-deficient cells showed decreased basal ROS generation and did not produce ROS in response to AngII. Unexpectedly, AngII-dependent Ca(2+) signaling was markedly decreased in NOX1-deficient cells. Immunostaining demonstrated that AT1R was localized on the plasma membrane in wild-type, but intracellularly in NOX1-deficient cells. Immunohistochemistry and immunoblotting showed a decreased expression of AT1R in the aorta of NOX1-deficient mice. To investigate the basis of the abnormal AT1R targeting, we studied caveolin expression and phosphorylation. The amounts of total caveolin and of caveolae were not different in NOX1-deficient mice, but a marked decrease occurred in the phosphorylated form of caveolin. Exogenous H(2)O(2) or transfection of a NOX1 plasmid restored AngII responses in NOX1-deficient cells. Based on these findings, we propose that NOX1-derived reactive oxygen species regulate cell-surface expression of AT1R through mechanisms including caveolin phosphorylation. The lack cell-surface AT1R expression in smooth muscle could be involved in the decreased blood pressure in NOX1-deficient mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19309260     DOI: 10.1089/ars.2009.2584

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  15 in total

1.  Activation of NADPH oxidase 1 increases intracellular calcium and migration of smooth muscle cells.

Authors:  Matthew C Zimmerman; Maysam Takapoo; Dammanahalli K Jagadeesha; Bojana Stanic; Botond Banfi; Ramesh C Bhalla; Francis J Miller
Journal:  Hypertension       Date:  2011-08-01       Impact factor: 10.190

Review 2.  Enzymatic regulation and functional relevance of NOX5.

Authors:  Feng Chen; Yusi Wang; Scott Barman; David J R Fulton
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 3.  Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.

Authors:  Grant R Drummond; Stavros Selemidis; Kathy K Griendling; Christopher G Sobey
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

Review 4.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

5.  NADPH oxidases: molecular understanding finally reaching the clinical level?

Authors:  Tomasz J Guzik; Kathy K Griendling
Journal:  Antioxid Redox Signal       Date:  2009-10       Impact factor: 8.401

Review 6.  Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical research.

Authors:  Augusto C Montezano; Rhian M Touyz
Journal:  Antioxid Redox Signal       Date:  2013-06-06       Impact factor: 8.401

7.  Binding of EBP50 to Nox organizing subunit p47phox is pivotal to cellular reactive species generation and altered vascular phenotype.

Authors:  Imad Al Ghouleh; Daniel N Meijles; Stephanie Mutchler; Qiangmin Zhang; Sanghamitra Sahoo; Anastasia Gorelova; Jefferson Henrich Amaral; Andrés I Rodríguez; Tatyana Mamonova; Gyun Jee Song; Alessandro Bisello; Peter A Friedman; M Eugenia Cifuentes-Pagano; Patrick J Pagano
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-18       Impact factor: 11.205

8.  NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling.

Authors:  Scott A Barman; Feng Chen; Yunchao Su; Christiana Dimitropoulou; Yusi Wang; John D Catravas; Weihong Han; Laszlo Orfi; Csaba Szantai-Kis; Gyorgy Keri; Istvan Szabadkai; Nektarios Barabutis; Olga Rafikova; Ruslan Rafikov; Stephen M Black; Danny Jonigk; Athanassios Giannis; Reto Asmis; David W Stepp; Ganesan Ramesh; David J R Fulton
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-06-19       Impact factor: 8.311

Review 9.  NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?

Authors:  Sanghamitra Sahoo; Daniel N Meijles; Patrick J Pagano
Journal:  Clin Sci (Lond)       Date:  2016-03       Impact factor: 6.124

Review 10.  NADPH oxidases: functions and pathologies in the vasculature.

Authors:  Bernard Lassègue; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11-12       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.